Lesiak, Aleksandra

Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*

Wollenberg, A., Blauvelt, A., Guttman‐Yassky, E., Worm, M., Lynde, C., Lacour, J. ‐., Spelman, L., Katoh, N., Saeki, H., Poulin, Y., et al. (2021) · British Journal of Dermatology

Dermatology and Skin DiseasesAsthma and respiratory diseases

Cited by 638

Blue Light in Dermatology

Sadowska, M., Narbutt, J., & Lesiak, A. (2021) · Life

Photodynamic Therapy Research StudiesDermatology and Skin Diseases

Cited by 74

Sunscreen applied at ≥ 2 mg cm −2 during a sunny holiday prevents erythema, a biomarker of ultraviolet radiation‐induced DNA damage and suppression of acquired immunity

Narbutt, J., Philipsen, P. A., Harrison, G. I., Morgan, K. A., Lawrence, K. P., Baczynska, K. A., Grys, K., Rogowski‐Tylman, M., Olejniczak‐Staruch, I., Tewari, A., et al. (2019) · British Journal of Dermatology

Skin Protection and AgingNonmelanoma Skin Cancer Studies

Cited by 40

The relationship between atopic dermatitis and atopic itch in children and the psychosocial functioning of their mothers: A cross-sectional study

Kobusiewicz, A. K., Tarkowski, B., Kaszuba, A., Lesiak, A., Narbutt, J., & Zalewska-Janowska, A. (2023) · Frontiers in Medicine

Dermatology and Skin DiseasesFamily and Disability Support Research

Cited by 20

Serum Biomarkers of Inflammation and Turnover of Joint Cartilage Can Help Differentiate Psoriatic Arthritis (PsA) Patients from Osteoarthritis (OA) Patients

Waszczykowski, M., Fabiś-Strobin, A., Bednarski, I., Lesiak, A., Narbutt, J., & Fabiś, J. (2020) · Diagnostics

Spondyloarthritis Studies and TreatmentsOsteoarthritis Treatment and Mechanisms

Cited by 9